title: Drug updates and approvals: 2016 in review.
abstract: In 2016, the FDA approved several new drugs for use in primary care. These drugs include amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT), elbasvir and grazoprevir (Zepatier), emtricitabine and tenofovir alafenamide (Descovy), glycopyrrolate and formoterol (Bevespi Aerosphere), insulin degludec injection (Tresiba), and ixekizumab (Taltz).
authors.affiliation: Lindsy Meadowcraft is an assistant professor, ambulatory care pharmacy at Wingate University, School of Pharmacy, Hendersonville, N.C. Geoffrey Mospan is an assistant professor, internal medicine at Wingate University School of Pharmacy, Wingate, N.C. Taylor Morrisette is a pharmD candidate at Wingate University, School of Pharmacy, Hendersonville, N.C. Katie Smart is a pharmD candidate at Wingate University, School of Pharmacy, Hendersonville, N.C. Melissa Janis is a pharmD candidate at Wingate University, School of Pharmacy, Hendersonville, N.C.
authors.forename: Lindsy
authors.initials: L
authors.lastname: Meadowcraft
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Mospan
authors.forename: Taylor
authors.initials: T
authors.lastname: Morrisette
authors.forename: Katie
authors.initials: K
authors.lastname: Smart
authors.forename: Melissa
authors.initials: M
authors.lastname: Janis